Castle Creek Arbitrage, LLC - ISIS PHARMACEUTICALS INC DEL ownership

Quarter-by-quarter ownership
Castle Creek Arbitrage, LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$150,000
-0.7%
150,0000.0%0.01%0.0%
Q2 2021$151,000
-1.3%
150,0000.0%0.01%
-11.1%
Q1 2021$153,000
-6.1%
150,0000.0%0.01%
-10.0%
Q4 2020$163,000
+4.5%
150,0000.0%0.01%
-16.7%
Q3 2020$156,000
-6.0%
150,0000.0%0.01%
-14.3%
Q2 2020$166,000
+8.5%
150,0000.0%0.01%
-44.0%
Q1 2020$153,000
-98.8%
150,000
-98.6%
0.02%
-99.2%
Q3 2019$12,253,000
-3.8%
10,734,0000.0%3.09%
-6.9%
Q2 2019$12,733,000
-12.3%
10,734,0000.0%3.32%
-22.2%
Q1 2019$14,515,000
+308.2%
10,734,000
+114.7%
4.27%
+1356.0%
Q2 2016$3,556,000
-22.1%
5,000,0000.0%0.29%
-19.9%
Q1 2016$4,564,0005,000,0000.37%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q4 2021
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders